Wednesday, September 16, 2026Latest filing Sep 14, 2026

AQUA Congressional Stock Trades

Evoqua Water Technologies Corp. (AQUA)

Last disclosed trade May 9

Every disclosed trade in AQUA by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Susie Lee · Sold $AQUA · May 9 · $15K–$50K

0.52MED
Disclosure speedx 0.250.60
Trade sizex 0.250.50
Cluster activityx 0.150.00
Track recordx 0.350.69

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $AQUA

Get notified when any member of Congress trades $AQUA. Free, no card, no spam.

Follow free →
1
Disclosed trades
0
Buys
1
Sells
1
Members trading

The record on $AQUA

Coldpine has parsed 1 disclosed trade in $AQUA by 1 member of Congress, drawn from 1 periodic transaction report dated May 9, 2023. It came from the House, filed by a Democrat.

The one trade with a known filing lag was reported 17 days after the trade date, inside the 45-day window the STOCK Act sets: a $AQUA sale by Susie Lee dated May 9, 2023, disclosed May 26, 2023. How late filing is measured across all of Congress is in the late-filers study.

The one trade that lists an account holder was reported under a spouse, dependent child, or joint account rather than the member directly.

Members who trade AQUA

Recent disclosed trades in AQUA

DateMemberTypeAmount
May 9Susie Lee(NV)sell$15K–$50K

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →